Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect? — Positive
PHAR Zacks Investment Research — November 10, 2025The mean of analysts' price targets for Pharming Group (PHAR) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe PRA Group (PRAA) Could Rally 53.69%: Here's is How to Trade — Positive
PRAA Zacks Investment Research — November 10, 2025The mean of analysts' price targets for PRA Group (PRAA) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 75.15% Upside in Orion Energy Systems (OESX): Can the Stock Really Move This High? — Positive
OESX Zacks Investment Research — November 10, 2025The consensus price target hints at a 75.2% upside potential for Orion Energy Systems (OESX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 35.5% Upside in SkyWest (SKYW): Here's What You Should Know — Positive
SKYW Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 35.5% in SkyWest (SKYW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now — Positive
SDGR Zacks Investment Research — November 10, 2025Schrodinger (SDGR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Wall Street Analysts Think Ultra Clean (UCTT) Could Surge 34.31%: Read This Before Placing a Bet — Positive
UCTT Zacks Investment Research — November 10, 2025The mean of analysts' price targets for Ultra Clean (UCTT) points to a 34.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Vericel (VCEL) Could Rally 39.42%: Here's is How to Trade — Positive
VCEL Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Believe Waystar (WAY) Could Rally 38.21%: Here's is How to Trade — Positive
WAY Zacks Investment Research — November 10, 2025The mean of analysts' price targets for Waystar (WAY) points to a 38.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts See a 26.85% Upside in Controladora Vuela (VLRS): Can the Stock Really Move This High? — Positive
VLRS Zacks Investment Research — November 10, 2025The consensus price target hints at a 26.9% upside potential for Controladora Vuela (VLRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Think Slide Insurance Holdings, Inc. (SLDE) Could Surge 33.73%: Read This Before Placing a Bet — Positive
SLDE Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 33.7% in Slide Insurance Holdings, Inc. (SLDE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Crexendo (CXDO) Have the Potential to Rally 33.63% as Wall Street Analysts Expect? — Positive
CXDO Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 33.6% in Crexendo (CXDO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts See a 50.76% Upside in GRINDR INC (GRND): Can the Stock Really Move This High? — Positive
GRND Zacks Investment Research — November 10, 2025The mean of analysts' price targets for GRINDR INC (GRND) points to a 50.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does Abacus Life, Inc. (ABL) Have the Potential to Rally 103.1% as Wall Street Analysts Expect? — Positive
ABL Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 103.1% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Believe Encore Capital Group (ECPG) Could Rally 27.35%: Here's is How to Trade — Positive
ECPG Zacks Investment Research — November 10, 2025The consensus price target hints at a 27.4% upside potential for Encore Capital Group (ECPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 30.54% Upside in ScanSource (SCSC): Here's What You Should Know — Positive
SCSC Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 30.5% in ScanSource (SCSC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Conmed (CNMD) Could Surge 25.54%: Read This Before Placing a Bet — Positive
CNMD Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Conmed (CNMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet — Positive
GHRS Zacks Investment Research — November 10, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 130.6% in GH Research (GHRS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Here's What You Should Know — Positive
CRMD Zacks Investment Research — November 10, 2025The mean of analysts' price targets for CorMedix (CRMD) points to an 80.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Here's is How to Trade — Positive
FOLD Zacks Investment Research — November 10, 2025The consensus price target hints at a 76.3% upside potential for Amicus Therapeutics (FOLD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of V.F. Corporation (VFC) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm — Neutral
VFC GlobeNewsWire — November 10, 2025ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding VFC's turnaround plan, Reinvent, including that additional significant reset actions would be necessary to return the Vans brand to growth, resulting in significant setbacks to Vans' revenue growth trajectory which were neither contemplated nor cautioned by Defendants' comments on Reinvent or the Vans turnaround progress, specifically.
